The role of surgery in the treatment of stage III non-small-cell lung cancer

Current Oncology Reports

Volumn 9, Issue 4, 2007, Pages 247-254

  Gallo, Amy M ^b   Donington, Jessica S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; NAVELBINE; PACLITAXEL; VINDESINE;

ADJUVANT THERAPY; ADVANCED CANCER; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAVA VEIN; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MICROMETASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PATIENT SELECTION; POSTOPERATIVE CARE; REVIEW; SPINE METASTASIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 34447291856     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-007-0030-3     Document Type: Review

References (47)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2006. CA Cancer J Clin 2006, 56:106-130.
2. Curran W, Jr., Scott C, Langer C, et al.: Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiation for patients with unresected stage III NSCLC (abstract 2499). Proc ASCO 2003, 22:621.
3. Sause W, Kolesar P, Taylor S IV, et al.: Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000, 117:358-364.
4. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
5. Oda M, Watanabe S, Tsukayama S, et al.: Results of resection of T3N0-2M0 non-small cell lung cancer according to involved organ and nodal status. Kyobu Geka 1998, 51:902-906.
6. Arriagada R, Bergman B, Dunant A, et al.: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
7. Douillard JY, Rosell R, Delena M: ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients: Final results after 70 month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. J Clin Oncol 2005, 23:624.
8. Pignon JP, Tribodet H, Scagliotti GV, et al.: Lung Adjuvant Cisplatin Evaluation (LACE): A polled analysis of five randomized clinical trials including 4584 patients [abstract]. Proc ASCO 2006, 24:366s.
9. Vansteenkiste JF, Stroobants SG, De Leyn PR et al.: Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998, 16:2142-2149.
10. Toloza EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003, 123(1 Suppl):137S-146S.
11. Hammoud ZT, Anderson RC, Meyers BF, et al.: The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg 1999, 118:894-899.
12. Albain KS, Rusch VW, Crowley JJ, et al.: Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
13. Goldstraw P: Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer. J Clin Oncol 2006, 24:3317-3318.
14. De Leyn P, Stroobants S, De Wever W, et al.: Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 2006, 24:3333-3339.
15. Martini N, Flehinger BJ: The role of surgery in N2 lung cancer. Surg Clin North Am 1987, 67:1037-1049.
16. Andre F, Grunenwald D, Pignon JP, et al.: Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000, 18:2981-2989.
17. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al.: Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature. Lung Cancer 1998, 19:3-13.
18. Casali C, Stefani A, Natali P, et al.: Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 2005,28:33-38.
19. Roth JA, Fossella F, Komaki R, et al.: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994, 86:673-680.
20. Rosell R, Maestre J, Font A, et al.: A randomized trial of mitomycin/ ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer. Semin Oncol 1994, 21(3 Suppl 4):28-33.
21. Pass HI, Pogrebniak HW, Steinberg SM, et al.: Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992, 53:992-998.
22. Nagai K, Tsuchiya R, Mori T, et al.: A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg 2003, 125:254-260.
23. Raez LE, Lilenbaum R: New developments in chemotherapy for advanced non-small cell lung cancer. Curr Opin Oncol 2006, 18:156-161.
24. Bueno R, Richards WG, Swanson SJ, et al.: Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000, 70:1826-1831.
25. Fowler WC, Langer CJ, Curran WJ, Jr., Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993, 55:986-989.
26. Albain KS, Swann RS, Rusch VW, et al.: Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIA (pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 2005, 23(16S):7014.
27. Daly BD, Fernando HC, Ketchedjian A, et al.: Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 2006, 82:227-231.
28. Sonett JR, Suntharalingam M, Edelman MJ, et al.: Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004, 78:1200-1205.
29. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998, 352:257-263.
30. Lally BE, Zelterman D, Colasanto JM, et al.: Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006, 24:2998-3006.
31. Sawyer TE, Bonner JA, Gould PM, et al.: Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 1997, 64:1402-1407.
32. Machtay M, Lee JH, Shrager JB, et al.: Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 2001, 19:3912-3917.
33. Bradley JD, Paulus R, Graham MV, et al.: Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group - RTOG 9705. J Clin Oncol 2005, 23:3480-3487.
34. Deslauriers J, Brisson J, Cartier R, et al.: Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg 1989, 97:504-512.
35. Mitchell JD, Mathisen DJ, Wright CD, et al.: Clinical experience with caninal resection. J Thorac Cardiovasc Surg 1999, 117:39-52.
36. Mitchell JD, Mathisen DJ, Wright CD, et al.: Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome. J Thorac Cardiovasc Surg 2001, 121:465-471.
37. Burt ME, Pomerantz AH, Bains MS, et al.: Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987, 67:987-1000.
38. Tsuchiya R, Asamura H, Kondo H, et al.: Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg 1994, 57:960-965.
39. Spaggiari L, Regnard JF, Magdeleinat P, et al.: Extended resectians for bronchogenic carcinoma invading the superior vena cava system. Ann Thorac Surg 2000, 69:233-236.
40. Spaggiari L, Leo F, Veronesi G, et al.: Superior vena cava system resections for lung and mediastinal malignancies. A single center experience in 70 case (abstract 218). Proceedings of the Society of Thoracic Surgeons 42nd Annual Meeting. Chicago, IL; 2006.
41. Shaw RR, Paulson DL, Kee JL: Treatment of superior sulcus tumors by irradiation followed by resection. Ann Surg 1961, 154:29-40.
42. Rusch VW, Giroux DJ, Kraut MJ, et al.: Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001, 121:472-483.
43. Grunenwald DH, Mazel C, Girard P, et al.: Radical en bloc resection for lung cancer invading the spine. J Thorac Cardiovasc Surg 2002, 123:271-279.
44. Keller SM, Adak S, Wagner H, et al.: A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000, 343:1217-1222.
45. Waller D, Peake MD, Stephens RJ, et al.: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004, 26:173-182.
46. Scagliotti GV, Fossati R, Torri V, et al.: Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003, 95:1453-1461.
47. Winton T, Livingston R, Johnson D, et al.: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352:2589-2597.